Monica Lopez, a nurse at Children's Hospital Los Angeles, prepares to administer the Pfizer/BioNTech COVID-19 vaccine to 3-year-old Callum Diaz-Cheng during the hospital's first round of vaccines ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA recently approved updated 2026-2027 COVID-19 vaccines from Moderna, Pfizer-BioNTech, ...
Pfizer (PFE) posted Q4 adjusted EPS of $0.66 beating the $0.57 consensus on $17.56B in revenue while its non-COVID portfolio grew 9% operationally, led by Abrysvo (+136%) and Lorbrena (+45%), plus a ...
Pfizer (NYSE:PFE | PFE Price Prediction) and Moderna (NASDAQ:MRNA) just closed the books on Q4 2025, and the contrast is striking. Pfizer leaned on a diversified non-COVID portfolio and a fresh push ...
Mon, May 4, 2026 at 2:09 PM UTC Moderna leaned on cost cuts and international expansion to soften a steep COVID revenue cliff. Two very different pharma stories, both shaped by life after the pandemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results